Keefe Bruyette raised the firm’s price target on Corebridge (CRBG) to $39 from $37 and keeps an Outperform rating on the shares. The firm is assuming “normal” Q2 equity market appreciation of 2% for life insurance companies, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRBG:
- Corebridge Financial Reports Q1 2025 Earnings
- Corebridge Financial’s Resilient Q1 Earnings Call Insights
- Corebridge price target raised to $35 from $34 at BofA
- Corebridge Financial, Inc.: Strong Growth Potential and Shareholder Value Despite Challenges
- Corebridge price target raised to $38 from $36 at Barclays